These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 489500)

  • 1. Cross-resistance of clinical isolates of Pseudomonas aeruginosa to five aminoglycosides.
    Legakis NJ; Tselentis J; Courtis KJ; Papavassiliou J
    J Antimicrob Chemother; 1979 Jul; 5(4):487-90. PubMed ID: 489500
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa isolates from different medical institutions.
    Nitzan Y; Sharon R; Maayan M; Steuerman C
    Isr J Med Sci; 1985 Oct; 21(10):798-803. PubMed ID: 3935600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
    Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
    Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination testing of colistin with telavancin and daptomycin.
    Milne KE; Gould IM
    J Antimicrob Chemother; 2014 Dec; 69(12):3440-1. PubMed ID: 25077490
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of antimicrobial resistance of Pseudomonas aeruginosa isolated from canine infections.
    Lin D; Foley SL; Qi Y; Han J; Ji C; Li R; Wu C; Shen J; Wang Y
    J Appl Microbiol; 2012 Jul; 113(1):16-23. PubMed ID: 22487022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
    Hocquet D; Berthelot P; Roussel-Delvallez M; Favre R; Jeannot K; Bajolet O; Marty N; Grattard F; Mariani-Kurkdjian P; Bingen E; Husson MO; Couetdic G; Plésiat P
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3531-6. PubMed ID: 17682106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antimicrobial drug combinations against Pseudomonas aeruginosa: beta-lactams and aminoglycosides.
    Martinetto P; Malcangi A; Penna R
    G Ital Chemioter; 1988; 35(1-3):17-21. PubMed ID: 3151486
    [No Abstract]   [Full Text] [Related]  

  • 11. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
    Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
    J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic disc sensitivity pattern of pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria.
    Fadeyi A; Akanbi AA; Nwabuisi C; Onile BA
    Afr J Med Med Sci; 2005 Sep; 34(3):303-6. PubMed ID: 16749366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status of the sensitivity of Pseudomonas aeruginosa to aminoglycosides in France].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):621-4. PubMed ID: 3095779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the sensitivity of clinical strains of Pseudomonas aeruginosa to aminoglycoside and beta-lactam antibiotics].
    Dzierzanowska D; Patzer J
    Med Dosw Mikrobiol; 1987; 39(2):105-10. PubMed ID: 3116356
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanisms of resistance to aminoglycosides in the genus Pseudomonas.
    Phillips I; King BA; Shannon KP
    J Antimicrob Chemother; 1978 Mar; 4(2):121-9. PubMed ID: 649532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of combinations of aminoglycosides with betalactamine on Pseudomonas aeruginosa strains in vitro].
    Meitert E; Petrescu AM; Chiru M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):41-50. PubMed ID: 3090675
    [No Abstract]   [Full Text] [Related]  

  • 20. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.